Corrigendum to "Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization" [Redox Biol. 56 (2022) 102452]
- PMID: 36481115
- PMCID: PMC9868641
- DOI: 10.1016/j.redox.2022.102566
Corrigendum to "Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization" [Redox Biol. 56 (2022) 102452]
Erratum for
-
Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization.Redox Biol. 2022 Oct;56:102452. doi: 10.1016/j.redox.2022.102452. Epub 2022 Aug 30. Redox Biol. 2022. PMID: 36084349 Free PMC article.
References
-
- Newell L.F., Cook R.J. Advances in acute myeloid leukemia. BMJ. 2021;37 - PubMed
Publication types
LinkOut - more resources
Full Text Sources